<unk>  is used in the treatment of acromegaly, due to both pituitary and non-pituitary growth hormone-secreting tumors, and the management of symptoms caused by neuroendocrine tumors, particularly carcinoid tumors and VIPomas. In the United States and Canada,<unk>  is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes TSH.<unk>  also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent. In Dec 2014 the US FDA approved<unk>  for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs). It is used for polycystic liver disease. It has also been shown that it reduces the volume by 264mls on average.
Lanreotide
Octreotide
Edotreotide
Metoclopramide
Fertirelin
Susoctocog alfa
Tenatoprazole
Rabeprazole